Generate Biomedicines, Inc. - Common Stock — Statistiche Finanziarie Trimestrali (NASDAQ:GENB)

Financials

Flusso di cassa derivante dalle attività operative -80.39 M — Flussi di cassa derivanti dalle attività di investimento -259.93 M — Liquidità derivante dalle attività di finanziamento 378.89 M — Liquidità libera -84.17 M —

Generate Biomedicines, Inc. - Common Stock

Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases.